- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Cipla Limited — Updates, 09-03-2026: General Updates
09-03-2026 | 10:50 pm
09-03-2026 | 10:50 pm
Cipla's US subsidiary is recalling unexpired Lanreotide Injection batches, leading to a temporary market supply shortage. This operational development could impact sales and market presence for the company.
No comments yet. Be the first to comment!